AQUACEL® Ag Advantage enhanced Hydrofiber™ dressings are soft, sterile dressings made from two layers of 1.2% ionic silver impregnated sodium carboxymethylcellulose fiber with added ethylenediaminetetraacetic acid disodium salt (EDTA) and benzethonium chloride and stitched together with strengthening fibers. AQUACEL® Ag Advantage combines two technologies – Hydrofiber™ and MORE THAN SILVER™ – to effectively manage biofilm within the dressing.
Drawtex® wound dressing's capillary, hydroductive and electrostatic actions, made possible by exclusive LevaFiber™ Technology, allow it to remove debris, control excessive wound exudate and draw out bacteria and harmful MMPs, setting the stage for wound healing or closure.
Zetuvit® Plus is suitable for the treatment of moderately to heavily exuding wounds. Offers excellent patient comfort and satisfaction, a superabsorbent core for fast absorption and retention of exudate even under compression.
3M™ Tegaderm™ Alginate Ag Silver Dressings provide the antimicrobial silver, soft-gelling absorbency and fiber strength that professionals need to manage critically colonized wounds at increased risk of infection.
ConvaMax™ Superabsorber is designed to address moderate to heavy exudate management concerns that standard dressings can’t address. Combines high absorption and retention to help prevent excess exudate from contributing to poor skin integrity. Can be used as a primary or secondary dressing. Ideal where there is a risk of skin damage due to high levels of exudate. Available in non-adhesive and silicone adhesive forms.
Disclaimer: Information regarding coding, coverage and payment is provide as a service to users. Every effort has been made to ensure the accuracy of the information. However, Kestrel Health Information, Inc. and its subsidiaries do not represent, guarantee or warranty that the coding, coverage and payment information is error-free or that payment will be received. Users should always verify coverage policy, medical necessity requirements and coding instructions, and should review bulletins issued by the specific payer.